Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maher Albitar
BCR-ABL Truncation Due to Premature Translation Termination as a Mechanism of Resistance to Kinase Inhibitors
Acta Haematologica
Medicine
Hematology
‹
1
2
Related publications
Stat3 Contributes to Resistance Toward BCR-ABL Inhibitors in a Bone Marrow Microenvironment Model of Drug Resistance
Molecular Cancer Therapeutics
Cancer Research
Oncology
BCR-ABL Tyrosine Kinase
Science-Business eXchange
Adherence to BCR-ABL Inhibitors: Issues for CML Therapy
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia
Haematologica
Hematology
Inhibition of Phosphotyrosine Phosphatase 1B Causes Resistance in BCR-ABL-Positive Leukemia Cells to the ABL Kinase Inhibitor STI571
Clinical Cancer Research
Cancer Research
Oncology
Incidence and Outcome of BCR‐ABL Mutated Chronic Myeloid Leukemia Patients Who Failed to Tyrosine Kinase Inhibitors
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Disruption of the BCR-Abl/Hsp90 Protein Complex: A Possible Mechanism to Inhibit BCR-Abl-Positive Human Leukemic Blasts by Novobiocin
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Broad Spectrum Alkynyl Inhibitors of T315I BCR-Abl
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery